Journals / Dicle Tıp Dergisi / 2021 / Cilt: 48 - Sayı: 3

Cardiac evaluation of pediatric patients diagnosed with cystic fibrosis

Kistik fibrozis tanılı çocuk hastaların kardiyak değerlendirilmesi

Pages
559–566
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: We think that our patients with a diagnosis of cystic fibrosis should be closely monitored in terms of right heart failure, arrhythmia and sudden death, since electrocardiographic changes that may cause arrhythmia and tricuspid annular plane systolic movement reflecting right ventricular systolic function are low compared to the control group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Chronic hypoxia, hypercapnia, dilatation of the right heart chambers and sympathomimetic drugs used in patients with cystic fibrosis may cause arrhythmia.
📊
Key Findings & Data:Methods: Fifty-one pediatric patients with a diagnosis of cystic fibrosis and 53 healthy children whose age and gender were compatible with the patient group were compared in terms of electrocardiographic data, right ventricular systolic pressure and tricuspid annular plane systolic movement showing right ventricular systolic functions.
💡
Conclusion & Impact:Conclusions: We think that our patients with a diagnosis of cystic fibrosis should be closely monitored in terms of right heart failure, arrhythmia and sudden death, since electrocardiographic changes that may cause arrhythmia and tricuspid annular plane systolic movement reflecting right ventricular systolic function are low compared to the control group.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Chronic hypoxia, hypercapnia, dilatation of the right heart chambers and sympathomimetic drugs used in patients with cystic fibrosis may cause arrhythmia. The aim of our study is to predict sudden death by comparing the electrocardiography and echocardiography data of pediatric patients with cystic fibrosis with the healthy control group and to draw attention to this in the follow-up of the patients. Methods: Fifty-one pediatric patients with a diagnosis of cystic fibrosis and 53 healthy children whose age and gender were compatible with the patient group were compared in terms of electrocardiographic data, right ventricular systolic pressure and tricuspid annular plane systolic movement showing right ventricular systolic functions. Results: While 22 (43.1%) of our cystic fibrosis patients were girls, the mean age was 107.9 ± 59.7 months. While 25 of the control group were girls (47.1%), the mean age was 108.1 ± 59.7 months. Heart rate (p = 0.03), QT dispersion (p = 0.002), QTc maximum (p = 0.01), and QTc dispersion (p = 0.002) were significantly higher in the patient group compared to the control group. Tricuspid annular plane systolic movement was found to be significantly lower in the patient group compared to the control group (p <0.001). Conclusions: We think that our patients with a diagnosis of cystic fibrosis should be closely monitored in terms of right heart failure, arrhythmia and sudden death, since electrocardiographic changes that may cause arrhythmia and tricuspid annular plane systolic movement reflecting right ventricular systolic function are low compared to the control group.

Özet

Amaç: Kistik fibrozis: kalbi de etkileyen ilerleyici organ disfonksiyonu ile karakterize, kompleks, multisistemik kronik bir hastalıktır. Kistik fibrozis hastalarında gelişen kronik hipoksi, hiperkapni, sağ kalp boşluklarının dilatasyonu ve kullanılan sempatomimetik ilaçlar aritmiye neden olabilir. Çalışmamızın amacı kistik fibrozis tanılı çocuk hastaların elektrokardiyografi ve ekokardiyografi verilerini sağlıklı kontrol grubu ile karşılaştırarak ani ölüm açısından öngörüde bulunmak ve hastaların takiplerinde buna dikkat çekmektir.Yöntemler: Elli bir kistik fibrozis tanılı çocuk hasta ile yaş ve cinsiyeti hasta grubu ile uyumlu olan 53 sağlıklı çocuk elektrokardiyografi verileri, sağ ventrikül sistolik basıncı ve sağ ventrikül sistolik fonksiyonlarını gösteren triküspit anüler düzlem sistolik hareketi açısından karşılaştırıldı.Bulgular: Kistik fibrozis tanılı hastalarımızın 22’si (%43,1) kız iken, yaş ortalaması 107,9±59,7 ay idi. Kotrol grubunun ise 25’i kız (%47,1) iken, yaş ortalaması 108,1±59,7 ay idi. Kontrol grubu ile karşılaştırıldığında, hasta grubunda kalp hızı (p=0.03), QT dispersiyonu (p=0.002), QTc maksimum (p=0.01), QTc dispersiyonu (p=0.002) anlamlı olarak daha yüksekti. Triküspit anüler düzlem sistolik hareketi hasta grubunda kontrol grubuna göre (p<0,001) anlamlı olarak düşük saptandı.Sonuç: Kistik fibrozis tanılı çocuk hastalarda, pulmoner kan basıncındaki artış kalp yetmezliğinin erken belirtisi olabilir. Bu tür kardiyak bozuklukların, akciğer fonksiyonunun kronik inflamasyonuna bağlı kademeli olarak ortaya çıkabileceğini ve bu nedenle hastaları klinik olarak stabil tutmak ve kistik fibrozisin ilerlemesinde kronik inflamasyonu mümkün olduğunca erken kontrol altına almak çok önemlidir. Kistik fibrozis tanılı hastalarımızın kontrol grubuna göre aritmiye sebep olabilecek elektrokardiyografi değişiklikleri ve sağ ventrikül sistolik fonksiyonunu yansıtan triküspit anüler düzlem sistolik hareketi düşük olduğu için sağ kalp yetmezliği, aritmi ve ani ölüm açısından yakından takip edilmeleri gerektiğini düşünüyoruz.

🔖

Cite This Article

TÜRE, M., ŞEN, V. (2021). Cardiac evaluation of pediatric patients diagnosed with cystic fibrosis. Dicle Tıp Dergisi, Cilt: 48 - Sayı: 3, 559–566. https://ajindex.com/articles/349426

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Moss AJ. The cardiovascular system in cystic fibrosis. Pediatrics 1982; 70: 728-41
  2. N. Ozcelik, R. Shell, M. Holtzlander, et al. Decreased right ventricular function in healthy pediatric cystic fibrosis patients versus non-cystic fibrosis patients Pediatr Cardiol. 2013; 34: 159-64
  3. RJ Bright-Thomas, AK Webb. Kistik fibrozda kalp JR Soc Med. 2002; 95: 2 - 10 4. Cheron G, Paradis K, Steru D, et al. Cardiac involvement in cystic fibrosis revealed by a ventricular arrhythmia. Acta Paediatr Scand 1984; 73: 697-700
  4. Sullivan MM, Moss RB, Hindi RD, et al. Supraventricular tachycardia in patients with cystic fibrosis. Chest 1986; 90: 239-42
  5. Shih HT, Webb CR, Conway WA, et al. Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. Chest 1988; 94: 44-8
  6. Pierson DJ, Hudson LD, Stark K, et al. Cardiopulmonary effects of terbutaline and a bronchodilator combination in chronic obstructive pulmonary disease. Chest 1980; 77: 176-82
  7. A. Baño-Rodrigo, A. Salcedo-Posadas, J.R. VillaAsensi, et al. Right ventricular dysfunction in adolescents with mild cystic fibrosis Journal of Cystic Fibrosis. 2012; 11: 274-80
  8. Z.M. Sellers, V. De Arcangelis, Y. Xiang, P.M. Best Cardiomyocytes with disrupted CFTR function require CaMKII and Ca(2+)-activated Cl(−) channel activity to maintain contraction rate J Physiol. 2010; 588: 2417-29
  9. T.P. Abraham, V.L. Dimaano, H.Y. Liang. Role of tissue Doppler and strain echocardiography in current clinical practice Circulation. 2007; 116: 2597-609
  10. Fraser KL, Tullis DE, Sasso Z, et al. Pulmonary Hypertension and Cardiac Function in Adult Cystic Fibrosis. Role of Hypoxemia. Chest 1999; 115: 1321– 8
  11. Lopez L, Colan SD, Frommelt PC, et al. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr 2010; 23: 465–95
  12. Lang RM, Bierig M, Devereux RB, et al. American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Eur J Echocardiogr 2006; 7: 79–88
  13. Stern RC, Borkat G, Hirschfeld SS, et al. Heart failure in cystic fibrosis. Treatment and prognosis of cor pulmonale